Technical Analysis for FREQ - Frequency Therapeutics, Inc.

Grade Last Price % Change Price Change
C 49.21 -0.73% -0.36
FREQ closed down 0.73 percent on Friday, February 26, 2021, on 79 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical FREQ trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Spinning Top Other 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish -0.73%
Multiple of Ten Bearish Other -0.73%
Wide Bands Range Expansion -0.73%
Crossed Above 20 DMA Bullish -6.05%
Wide Bands Range Expansion -6.05%
Fell Below 20 DMA Bearish 1.40%
Older End-of-Day Signals for FREQ ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 18 hours ago
Down 2 % about 18 hours ago
Down 1% about 18 hours ago
Fell Below Previous Day's Low about 18 hours ago
20 DMA Resistance about 18 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Frequency Therapeutics is a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Frequency’s progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapeutics. The company’s lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss, the most common form of hearing loss. The company is also evaluating its PCA approach in additional diseases, including multiple sclerosis.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Clinical Development Disease Occupational Safety And Health Hearing Multiple Sclerosis Degenerative Disease Degenerative Diseases Perception Audiology Hearing Loss Progenitor Cell Deafness Auditory System Sensorineural Hearing Loss Hair Cell

Is FREQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 58.33
52 Week Low 14.5
Average Volume 298,422
200-Day Moving Average 27.07
50-Day Moving Average 41.87
20-Day Moving Average 50.57
10-Day Moving Average 52.29
Average True Range 4.26
ADX 44.6
+DI 21.29
-DI 18.50
Chandelier Exit (Long, 3 ATRs ) 45.55
Chandelier Exit (Short, 3 ATRs ) 50.70
Upper Bollinger Band 58.18
Lower Bollinger Band 42.96
Percent B (%b) 0.41
BandWidth 30.10
MACD Line 2.87
MACD Signal Line 3.78
MACD Histogram -0.9099
Fundamentals Value
Market Cap 1.66 Billion
Num Shares 33.7 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -77.44
Price-to-Sales 29.89
Price-to-Book 4.75
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.04
Resistance 3 (R3) 57.25 54.85 55.73
Resistance 2 (R2) 54.85 52.86 54.74 55.30
Resistance 1 (R1) 52.03 51.62 50.83 51.82 54.86
Pivot Point 49.63 49.63 49.03 49.52 49.63
Support 1 (S1) 46.81 47.64 45.61 46.60 43.56
Support 2 (S2) 44.41 46.40 44.31 43.12
Support 3 (S3) 41.59 44.41 42.69
Support 4 (S4) 41.38